|
|
|
By Craig Tooman, Silence Therapeutics | Silence Therapeutics has two wholly owned siRNA therapies now in clinical trials and one partnered program with AstraZeneca. Silence's CEO discusses the need for good science, making smart business decisions, and cultivating partnerships. |
|
|
|
|
|
|
|
| An Introduction To Organ-On-A-Chip Technology | e-book | Emulate | Discover how Organ-on-a-Chip technology revolutionizes drug development, overcoming the limitations of traditional models to create more accurate, efficient pathways to life-saving treatments. |
|
|
| Bispecific Antibodies Unleashed | White Paper | Curia | Explore how leveraging expert CDMO partnerships can streamline the development process and enhance the efficacy of your bispecific antibody therapies. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|